Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Journal of clinical oncology. [Englische Ausgabe]
Year: 2011, Jahrgang: 29, Heft: 12, Pages: 1634-1642 |
| ISSN: | 0732-183X |
| Online-Zugang: |
|
| Verfasserangaben: | Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine Pletsch, Ulrike Proetel, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Mathias Hänel, Markus Pfirrmann, Stefan W. Krause, Christoph Nerl, Hans Pralle, Alois Gratwohl, Dieter K. Hossfeld, Joerg Hasford, Andreas Hochhaus, and Susanne Saussele |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 730417913 | ||
| 003 | DE-627 | ||
| 005 | 20220810021324.0 | ||
| 007 | tu | ||
| 008 | 121123s2011 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)730417913 | ||
| 035 | |a (DE-576)9730417911 | ||
| 035 | |a (DE-599)GBV730417913 | ||
| 035 | |a (OCoLC)1340137427 | ||
| 035 | |a (OLC)1868016072 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 245 | 1 | 0 | |a Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia |c Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine Pletsch, Ulrike Proetel, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Mathias Hänel, Markus Pfirrmann, Stefan W. Krause, Christoph Nerl, Hans Pralle, Alois Gratwohl, Dieter K. Hossfeld, Joerg Hasford, Andreas Hochhaus, and Susanne Saussele |
| 264 | 1 | |c 2011 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Lauseker, Michael |d 1981- |e VerfasserIn |0 (DE-588)1058710265 |0 (DE-627)79743223X |0 (DE-576)414848438 |4 aut | |
| 700 | 1 | |a Jung-Munkwitz, Susanne |d 1972- |e VerfasserIn |0 (DE-588)129818496 |0 (DE-627)481322361 |0 (DE-576)297851373 |4 aut | |
| 700 | 1 | |a Leitner, Armin |d 1968- |e VerfasserIn |0 (DE-588)124123406 |0 (DE-627)706545435 |0 (DE-576)294029427 |4 aut | |
| 700 | 1 | |a Müller, Martin Christian |d 1972- |e VerfasserIn |0 (DE-588)121360296 |0 (DE-627)705409236 |0 (DE-576)181482819 |4 aut | |
| 700 | 1 | |a Pletsch, Nadine |e VerfasserIn |0 (DE-588)1065689802 |0 (DE-627)816570841 |0 (DE-576)425385329 |4 aut | |
| 700 | 1 | |a Proetel, Ulrike |e VerfasserIn |0 (DE-588)106568956X |0 (DE-627)816570523 |0 (DE-576)425384837 |4 aut | |
| 700 | 1 | |a Haferlach, Claudia |e VerfasserIn |0 (DE-588)1206213272 |0 (DE-627)1691999199 |4 aut | |
| 700 | 1 | |a Schlegelberger, Brigitte |d 1956- |e VerfasserIn |0 (DE-588)133666115 |0 (DE-627)550183779 |0 (DE-576)30001029X |4 aut | |
| 700 | 1 | |a Balleisen, Leopold |d 1943- |e VerfasserIn |0 (DE-588)1146399782 |0 (DE-627)1007913886 |0 (DE-576)186039204 |4 aut | |
| 700 | 1 | |a Hänel, Mathias |d 1964- |e VerfasserIn |0 (DE-588)17362295X |0 (DE-627)698532414 |0 (DE-576)134465970 |4 aut | |
| 700 | 1 | |a Pfirrmann, Markus |d 1967- |e VerfasserIn |0 (DE-588)133124932 |0 (DE-627)534963617 |0 (DE-576)299639835 |4 aut | |
| 700 | 1 | |a Krause, Stefan W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nerl, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pralle, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gratwohl, Alois |d 1947- |e VerfasserIn |0 (DE-588)1089795653 |0 (DE-627)853608105 |0 (DE-576)460543067 |4 aut | |
| 700 | 1 | |a Hossfeld, Dieter K. |d 1938- |e VerfasserIn |0 (DE-588)1055746471 |0 (DE-627)793793335 |0 (DE-576)411243020 |4 aut | |
| 700 | 1 | |a Hasford, Joerg |d 1950-2021 |e VerfasserIn |0 (DE-588)109611675 |0 (DE-627)484973878 |0 (DE-576)289647487 |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 773 | 0 | 8 | |i in |t Journal of clinical oncology. [Englische Ausgabe] |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 29(2011), 12 vom: 20. Apr., Seite 1634-1642 |w (DE-627)130399477 |w (DE-600)604914-X |w (DE-576)015903079 |x 0732-183X |7 nnas |a Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia |
| 773 | 1 | 8 | |g volume:29 |g year:2011 |g number:12 |g day:20 |g month:04 |g pages:1634-1642 |g extent:9 |a Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Hehlmann, Rüdiger, 1941 - |t Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia |d 2011 |w (DE-627)180073123X |
| 951 | |a AR | ||
| 992 | |a 20220503 | ||
| 993 | |a Article | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 20 |y j | ||
| 998 | |g 1107039339 |a Hochhaus, Andreas |m 1107039339:Hochhaus, Andreas |d 60000 |d 61200 |e 60000PH1107039339 |e 61200PH1107039339 |k 0/60000/ |k 1/60000/61200/ |p 19 | ||
| 998 | |g 106568956X |a Proetel, Ulrike |m 106568956X:Proetel, Ulrike |d 60000 |d 61200 |e 60000PP106568956X |e 61200PP106568956X |k 0/60000/ |k 1/60000/61200/ |p 7 | ||
| 998 | |g 121360296 |a Müller, Martin Christian |m 121360296:Müller, Martin Christian |d 60000 |d 61200 |e 60000PM121360296 |e 61200PM121360296 |k 0/60000/ |k 1/60000/61200/ |p 5 | ||
| 998 | |g 124123406 |a Leitner, Armin |m 124123406:Leitner, Armin |d 60000 |d 61200 |e 60000PL124123406 |e 61200PL124123406 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 998 | |g 129818496 |a Jung-Munkwitz, Susanne |m 129818496:Jung-Munkwitz, Susanne |d 60000 |d 61200 |e 60000PJ129818496 |e 61200PJ129818496 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |d 60000 |e 60000PH1037003489 |e 61200PH1037003489 |e 60000PH1037003489 |k 0/60000/ |k 1/60000/61200/ |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN730417913 |e 4128470066 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"730417913","name":{"displayForm":["Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine Pletsch, Ulrike Proetel, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Mathias Hänel, Markus Pfirrmann, Stefan W. Krause, Christoph Nerl, Hans Pralle, Alois Gratwohl, Dieter K. Hossfeld, Joerg Hasford, Andreas Hochhaus, and Susanne Saussele"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"titleAlt":[{"title":"Journal of clinical oncology / Englische Ausgabe"},{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"}],"origin":[{"dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Grune & Stratton ; Saunders ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; New York, NY ; Duluth, Minn. ; Baltimore, MD [u.a.]"}],"title":[{"partname":"[Englische Ausgabe]","title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title":"Journal of clinical oncology"}],"type":{"bibl":"periodical"},"part":{"year":"2011","text":"29(2011), 12 vom: 20. Apr., Seite 1634-1642","pages":"1634-1642","extent":"9","volume":"29","issue":"12"},"language":["eng"],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"disp":"Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemiaJournal of clinical oncology. [Englische Ausgabe]","id":{"eki":["130399477"],"issn":["0732-183X"],"zdb":["604914-X"]},"pubHistory":["1.1983 -"],"recId":"130399477"}],"id":{"eki":["730417913"]},"person":[{"given":"Rüdiger","role":"aut","display":"Hehlmann, Rüdiger","family":"Hehlmann"},{"family":"Lauseker","display":"Lauseker, Michael","role":"aut","given":"Michael"},{"family":"Jung-Munkwitz","display":"Jung-Munkwitz, Susanne","role":"aut","given":"Susanne"},{"given":"Armin","role":"aut","display":"Leitner, Armin","family":"Leitner"},{"display":"Müller, Martin Christian","family":"Müller","role":"aut","given":"Martin Christian"},{"family":"Pletsch","display":"Pletsch, Nadine","given":"Nadine","role":"aut"},{"family":"Proetel","display":"Proetel, Ulrike","role":"aut","given":"Ulrike"},{"display":"Haferlach, Claudia","family":"Haferlach","given":"Claudia","role":"aut"},{"role":"aut","given":"Brigitte","display":"Schlegelberger, Brigitte","family":"Schlegelberger"},{"family":"Balleisen","display":"Balleisen, Leopold","role":"aut","given":"Leopold"},{"family":"Hänel","display":"Hänel, Mathias","given":"Mathias","role":"aut"},{"given":"Markus","role":"aut","family":"Pfirrmann","display":"Pfirrmann, Markus"},{"role":"aut","given":"Stefan W.","display":"Krause, Stefan W.","family":"Krause"},{"display":"Nerl, Christoph","family":"Nerl","given":"Christoph","role":"aut"},{"display":"Pralle, Hans","family":"Pralle","given":"Hans","role":"aut"},{"role":"aut","given":"Alois","family":"Gratwohl","display":"Gratwohl, Alois"},{"family":"Hossfeld","display":"Hossfeld, Dieter K.","role":"aut","given":"Dieter K."},{"given":"Joerg","role":"aut","family":"Hasford","display":"Hasford, Joerg"},{"display":"Hochhaus, Andreas","family":"Hochhaus","given":"Andreas","role":"aut"},{"given":"Susanne","role":"aut","family":"Saußele","display":"Saußele, Susanne"}],"language":["eng"],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"type":{"bibl":"article-journal"},"title":[{"title":"Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia","title_sort":"Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia"}]} | ||
| SRT | |a HEHLMANNRUTOLERABILI2011 | ||